Gabapentin in Headache Disorders: What Is the Evidence?

ConclusionDespite the conflicting evidence surrounding select studies, a significant amount of evidence shows that GBP has benefit for a majority of primary headache syndromes, including chronic daily headaches. GBP has some efficacy in migraine headache, but not sufficient evidence to suggest primary therapy. When primary headache treatments fail, a GBP trial may be considered in the individual patient.

Source: Pain Medicine - September 23, 2015 Category: Anesthesiology Authors: Michael D. Perloff, Rachel K. Berlin, Marshall Gillette, Matthew J. Petersile, Donna Kurowski Tags: Review Source Type: research